SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950170-24-049448
Filing Date
2024-04-29
Accepted
2024-04-29 08:39:11
Documents
14
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A acor-20231231.htm   iXBRL 10-K/A 754755
2 EX-31.1 acor-ex31_1.htm EX-31.1 6605
3 EX-31.2 acor-ex31_2.htm EX-31.2 6733
4 EX-97 acor-ex97.htm EX-97 30536
  Complete submission text file 0000950170-24-049448.txt   1058058

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acor-20231231.xsd EX-101.SCH 39672
17 EXTRACTED XBRL INSTANCE DOCUMENT acor-20231231_htm.xml XML 10157
Mailing Address TWO BLUE HILL PLAZA PEARL RIVER NY 10965
Business Address TWO BLUE HILL PLAZA PEARL RIVER NY 10965 914-347-4300
Acorda Therapeutics, Inc. (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 133831168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-31938 | Film No.: 24886769
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)